申请人:Nirogi Ramakrishna
公开号:US20130005709A1
公开(公告)日:2013-01-03
The present invention relates to novel sulfone compounds as 5-HT
6
receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them.
The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them.
These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT
6
receptor functions.
本发明涉及一种新型砜化合物,作为式(I)的5-HT6受体配体,以及它们的衍生物、前药、互变异构体、立体异构体、多晶形态、溶剂合物、水合物、代谢物、N-氧化物、药学上可接受的盐和含有它们的组合物。本发明还涉及上述新型化合物的制备方法,以及它们的衍生物、前药、互变异构体、立体异构体、多晶形态、溶剂合物、水合物、代谢物、N-氧化物、药学上可接受的盐和含有它们的组合物。这些化合物在治疗/预防与5-HT6受体功能相关的各种疾病方面是有用的。